ArticleThe Journal of rheumatology2021

Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Jason M Springer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.